← SynDRA
PALUPIPRANT
SynDRA canonical compound SYN0038381 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | PTGER4 |
|---|
| Mechanism of action | prostanoid receptor antagonist |
|---|
All known targets
Mechanisms of action (all sources)
- PTGER4 ANTAGONIST
- prostanoid receptor antagonist
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- PTGER2
- ADGRF1
- GPR119
- TDG
- SMUG1
- S1PR1
- PTGER3
- PTGER1
- OGG1
- NTHL1
- NEIL2
- NEIL1
- MUTYH
- MBD4
- GPR35
- GLP1R
- ADRA2A
- FPR2
- FFAR4
- CYP3A4
- CYP2E1
- CYP2D6
- CYP2C9
- CYP2B6
- CYP1A2
- CX3CR1
- C5AR1
- APLNR
- AGTR1
- ADRB2
- UNG
Cross-references
Synonyms
- E 7046
- ER 886046
- E7046
- MKLKAQMPKHNQPR-NSHDSACASA-N
- UNII-YWY620GU8I
- E-7046
- YWY620GU8I
- ER-886046
- SCHEMBL881212
- CHEMBL3670685
- MolPort-044-561-624
- BDBM119448
- EX-A1726
- ZINC114766778
- CS-7559
- Benzoic acid, 4-((1S)-1-(((3-(difluoromethyl)-1-methyl-5-(3-(trifluoromethyl)phenoxy)-1H-pyrazol-4-yl)carbonyl)amino)ethyl)-
- AC-30338
- HY-103088
- US8686018, 107
- (S)-4-(1-(3-(difluoromethyl)-1-methyl-5-(3-(trifluoromethyl)phenoxy)-1H-pyrazole-4-carboxamido)ethyl)benzoic acid
- 4-[(1S)-1-[[3-(difluoromethyl)-1-methyl-5-[3-(trifluoromet
- AN0025
- RefChem:169781
- EP4 Inhibitor E7046
- EP4 Antagonist E7046
- AN-0025
- Prostaglandin E EP4 Receptor Antagonist E7046
- Prostaglandin E2 EP4 Receptor Inhibitor AN0025
- MFCD30502665
- PALUPIPRANT [INN]
- orb1296261
- SCHEMBL29517740
- GTPL14139
- C22H18F5N3O4
- E 7046 [WHO-DD]
- NSC804040
- s6649
- ER 886046 [WHO-DD]
Look up PALUPIPRANT in the interactive SynDRA portal →